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Abstract
Background: Cardiovascular disease (CVD) is a leading cause of death in Europe. In Germany, a declining mortality
rate from acute myocardial infarction (AMI) has been observed in the last decades. Nevertheless, there are large
differences between the federal states when looking at the mortality and morbidity of AMI. Saxony-Anhalt is one of
the federal states with the highest mortality rates for AMI in Germany. In 2012, the regional myocardial infarction
registry of Saxony-Anhalt (RHESA) was established to investigate the individual, infrastructural, and health care factors
with respect to an urban (city of Halle) and rural (region of Altmark) population. For detailed observation the
RHESA-CARE study was conducted in 2014. RHESA-CARE focuses on the symptoms during infarction, the behaviour of
patients while alerting for infarction, the use of rehabilitation possibilities, and long-term care.
Methods/Design: RHESA-CARE is an extended baseline survey of AMI patients registered in RHESA who are aged 25
or more, and inhabitants of the city of Halle (Saale) or the district of Altmark in the federal state of Saxony-Anhalt,
Germany. Detailed information was collected on classical and psychosocial cardiovascular risk factors as well as factors
of alerting behaviour, first aid, and utilization of medical and rehabilitation services. High data quality is ensured by a
detailed system of quality control.
Discussion: RHESA-CARE has the main objective to investigate factors that influence morbidity and mortality rates
due to AMI. Another purpose is the comparison of a rural and urban patient population. It provides an opportunity to
serve as a base for improvement of patients’ behaviour and health care as well as further research.
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Background
Worldwide, cardiovascular disease (CVD) is a public
health problem contributing to 30 % of global mortality
(15,616.1 million deaths) and 10 % of the global disease
burden [1, 2]. CVD remains also the leading cause of death
among Europeans. Over a third of deaths from CVD in
the EU are from coronary heart disease (CHD) [3]. One of
the five main manifestations of CHD is acute myocardial
infarction (AMI). Since 1980 in Germany, the mortality
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rates of AMI have been declining [4]. However, looking at
the occurrence of AMI there are large differences between
the federal states of Germany regarding the mortality and
morbidity. While in 2012 the age-standardized mortal-
ity rate for AMI in Germany was 46 deaths per 100,000
inhabitants, Saxony-Anhalt, a federal state in the eastern
part of Germany, has a mortality rate of 67 per 100,000
inhabitants (age-adjusted). However, for Bavaria, a federal
state in the southern part of Germany, 47 deaths by AMI
per 100,000 inhabitants (age-adjusted) was observed [5].
Saxony-Anhalt is one of the federal states with the highest
mortality rates for AMI in Germany. The reasons are still
unclear and speculative. Different factors were discussed
which could be divided into two fields.
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First, individual factors:
• high prevalence of cardiovascular risk factors in
Saxony-Anhalt [6, 7],
• low socio-economic level, high unemployment
[8–10],
• less use of medical services (ambulant as well as
post-hospital) [11],
• alerting behaviour during AMI [12, 13], and
• adherence to medication [14].
Second, structural factors:
• lower doctor density (family doctor and cardiologist),
• low number of first aiders in the population [15],
• guideline care (GLC) ([16, 17]),
• use of german disease management programs (DMP)
([18, 19]),
• insufficient access to rehabilitation units,
• insufficient access to heart training groups, and
• not satisfying guideline medication [16].
To answer the question of which factors influence the
mortality rate in Saxony-Anhalt, the regional myocar-
dial infarction registry of Saxony-Anhalt (RHESA) was
established in 2012. It investigated some of the factors
mentioned above and is described elsewhere [20]. RHESA
focuses on the comparison of an urban (city of Halle)
and rural (region of Altmark) region. Data collected in
RHESA enabled us to assess different levels of quality
of health care of patients with AMI (structural, process,
and outcome) in these areas. In the registry, we were
not able to survey all individual and structural factors
mentioned above. Therefore, we conducted an extended
baseline survey in 2014. This extension, namely RHESA-
CARE, focuses on the symptoms during infarction, the
behaviour of patients while alerting for infarction, the
use of rehabilitation facilities (multidisciplinary rehabil-
itation programs, and heart training groups), and long-
term care. Furthermore, we plan a follow-up of the MI
patients after 2 years of baseline. Here we will examine
the occurrence of major adverse cardiac events (MACE)
as well as changes in individual cardiovascular risk fac-
tors. This paper presents the design and objectives of
RHESA-CARE.
The aims of RHESA-CARE are:
• profile the individual factors of AMI patients
(Table 1) at baseline and 2 years of follow-up,
• detect differences in these risk factors between the
rural and urban populations of Saxony-Anhalt,
• elucidate reasons for regional variations in structural
factors, e.g. availability of a cardiologist, family
doctors, and heart training groups,
Table 1 Overview of certain factors in RHESA-CARE split by the
time points before/during/after AMI
Structural factors Individual factors
Before AMI Availability of family doctor Cardiovascular risk factors
Availability of cardiologist Use of medical services
Medication
Long-term care
During AMI Availability of first aider symptoms
alerting behaviour
After AMI Availability of rehabilitation Risk factors
programmes Use of rehabilitation
programmes
Use of heart training
groups
Availability of heart training Medication
groups Long-term care
• examine the influence of individual and structural
risk factors and determents like guideline care, heart
training groups, and disease management programs
on the occurrence of major adverse cardiac events
(MACE),
• examine the change in risk profile between baseline
and follow-up, and




RHESA-CARE is a extended baseline survey with a
planned 2 years follow-up of AMI patients registered in
RHESA. RHESA-CARE has been conducted since May
2014 at the Institute of Medical Epidemiology, Biostatis-
tics, and Informatics (IMEBI). It is being funded by the
Wilhelm Roux Program of the Faculty of Medicine of the
Martin Luther University Halle-Wittenberg.
Study population
RHESA includes patients with AMI aged 25 years or
more. They have to be inhabitants of the city of Halle
(Saale) or of the rural district Altmark in the federal state
Saxony-Anhalt, Germany [20]. RHESA-CARE comprises
all patients from RHESA who have survived AMI and
agree with the survey (N = 600 per year). All inclusion
criteria are shown in Table 2.
We include all surviving AMI patients occurring after
April 2014. For RHESA-CARE we expect a response of
80 % from all eligible patients. We had to exclude patients
who were not capable of completing the interview in
German.
Recruitment of patients and data collection
The recruitment includes at least two written invitations
and active contact attempts by the study personnel via
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Table 2 Inclusion criteria of RHESA-CARE patients
Characteristics
Diagnosis Survived AMI since April 2014
Age at diagnosis 25 years and older
Residence City of Halle (Saale)
District of Altmark
Language Being capable to complete the interview in German
telephone if the patient does not respond to the written
invitations (Fig. 1). Six weeks after discharge from hos-
pital, we contact the patients with a covering letter and
a patient information flyer about RHESA-CARE by mail
(first contact phase). Patients with a known telephone
number are identified and were contacted four working
days after the postal contact by telephone. The first con-
tact phase contains 10 phone calls at different times and
days. If no contact can be made over at least two weeks, a
reminder invitation is mailed to the subject (second con-
tact phase). This phase corresponds to the first phase:
covering letter and telephone contact. For those patients
without a registered telephone number, two invitation let-
ters with reply-paid envelope are sent. If the patient agrees
to the survey, a computer assisted telephone interview
(CATI) is fixed, and we submit a confirmation of appoint-
ment with additional information. We inform the patients
to prepare a list of medication before and after the AMI
and hold the address of the family doctor. Responders,
who are not able to conduct the CATI (deafness, lack of
concentration, or physical disability) obtain a postal self-
administered questionnaire. This questionnaire includes
the same items as the CATI.
If we were not able to reach the patient we checked
address by the respective registry office. Should the
address changed, we start the first contact phase again.
When it was impossible to reach the patient or the patient
does not agree to take part in our study we send them a
self-administered non-responder questionnaire.
After the implementation of the CATI, or the self-
administered questionnaire, we send a self-administered
questionnaire to the family doctor, with a request to
answer it, and return copies of the discharge summary
from the hospital and rehabilitation unit.
Questionnaire
After selection of interview items, a pilot study was per-
formed to test the instruments and logistics of data col-
lection. Slight modifications were made before the main
phase of RHESA-CARE started in January 2015. The
CATI includes classical and psychosocial cardiovascular
risk factors as well as factors of alerting behaviour, first aid,
and utilization of medical and rehabilitation services. We
use highly standardized and validated instruments of data
collection which have been applied in several completed
or ongoing studies to ensure qualitiy of data and compa-
rability. Questionnaire items were selected and adapted
from:
• MONICA/KORA myocardial infarction registry
(Cooperative Health Research in the Region of
Augsburg) and it‘s postal questionnaire wave in 2011
(KORA-DMP) [19, 21, 22],
• CARLA study (CARdiovascular disease, Living and
Ageing in Halle) [23],
• DIOS study (Diagnosis Optimisation Study) [24], and
RHESA-CARE
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Fig. 1 Recruitment scheme of RHESA-CARE
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• IRENA (evaluation of the Intensified Rehabilitation
Aftercare Program) [25].
For some special items we developed questions. Details
on the sources of the questionnaire modules are listed in
Table 3.
We used a non-responder questionnaire to identify pos-
sible structural differences between responder and non-
responder. This questionnaire is a short version of the
responder questionnaire and contains 15 items for cardio-
vascular disease, rehabilitation, body mass index (BMI),
health condition, need for care, and social status. Further-
more, we prepared a questionnaire for the family doctor
(FDQ). The FDQ contains the items: blood values, blood
pressure, medication before/after AMI, and German dis-
ease management program (DMP) [18].
Quality management
The study was designed to fulfil the recommendations
of the German Good Epidemiologic Practices [26]. We
include several procedures for quality assurance. Before
the main study started, the standard operating procedures
(SOPs) were written and a pilot study was conducted. The
aim of the pilot study was to test the time plan and the
questionnaires.
• After an initial interviewer training course,
interviewers were monitored regularly. In addition,
we have regular discussions with the interviewers to
resolve questions.
• The recruitment progress, given as the number of
registered patients, is monitored monthly.
• A plausibility control of the interview data is done
monthly and is the basis for regular discussions with
the interviewers.
• The self-administered questionnaires are edited
visually by the study personnel before the data are
entered into the database. Self-administered
questionnaires with incomplete information or
missing data are marked and questions are prepared
for requesting by telephone.
• The FDQ is used to compare the doctors information
with that of the patient as well as to complete the
data of the patient if necessary.
Statistical analysis
In the baseline survey we are focused on explorative anal-
ysis. Therefore, we plan a descriptive analysis of individual
and structural factors. To give an overview of possi-
ble differences in urban and rural patients, for example
the behaviour of alerting, participation in cardiovascu-
lar rehabilitation, and utilization of medical services, we
will perform stratified analysis. Furthermore, we focus on
gender differences in factors like symptoms ofMI, depres-
sion, and participation in cardiovascular rehabilitation.
To examine the influence of risk factors and structural
Table 3 Topics, sub-categories, and sources of the responder questionnaire used in RHESA-CARE
Topic Sub-categories Source
Cardiovascular disease Previous MI, cardiac interventions Adopted from CARLA
symptomatic, situation while AMI, stroke, angina pectoris,
dyspnoea, fluid retention, atrial fibrillation, blood pressure,
cholesterol levels
Adopted from MONICA/KORA and KORA-DMP
First aid RHESA-CARE
Diabetes Type of diabetes, intervention, blood sugar concentration, interval
of measurement
Adopted from MONICA/KORA
Utilization of medical services Consultation rates, medical assistance, patient education (blood
pressure, diabetes, haemodilution), DMP programs
Adopted from MONICA/KORA and KORA-DMP
family doctor RHESA-CARE
Rehabilitation Cardiac rehabilitation, heart training groups RHESA-CARE
Life style Smoking behaviour Adopted from BGS98-Questionaire [27]
BMI, physical activity Adopted from MONICA/KORA
Medication Medication before/after AMI, medication use Adopted from MONICA/KORA, MMAS4 ([28, 29])
also used in MONICA/KORA
Health condition Health condition EQ-5D-3L [30] also used in MONIKA/KORA
Depression GDS [31, 32]
Care dependency Care level before/after AMI, use of care service before/after AMI Adopted from MONICA/KORA
Social status Socio-economic and employment status Adopted from CARLA, DIOS [33], and IRENA
Health insurance Adopted from MONICA/KORA
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factors on the occurrence of MACE, we use multiple Cox-
regression. For analysis of changing in risk profile we
use descriptive statistics. We use SAS®, Version 9.4 (SAS
Institutes, Cary, NC), as well as R®(Version 3.0.3) for the
analysis.
Discussion
Saxony-Anhalt is one of the federal states of Germany
with the highest AMI mortality and morbidity rates. The
causes are unclear and need to be surveyed. In previous
studies, different factors at an individual patient level were
discussed, as well as structural conditions and the quality
of process factors.
RHESA-CARE is an extended baseline survey with the
aim of a follow-up after 2 years. The main objective of
RHESA-CARE is to investigate factors that influence mor-
bidity and mortality rates due to AMI. Another purpose is
the comparison of a rural and urban AMI patient popu-
lation. Because of the selection of standardized interview
items applied in other regional studies with the data of
RHESA-CARE, a comparison with other registers like
MONICA/KORA is possible.
Both RHESA and RHESA-CARE enable us to assess dif-
ferent levels of quality of health care of patients with AMI
(structural, process and outcome). In particular, the com-
parison of rural and urban differences of structural effects
and lifestyle components could be described.
The study serves as a base for improvement of patients’
behaviour and health care as well as further research of
the named risk factors.
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